Plus Therapeutics Inc (PSTV)
NASDAQ · Healthcare
Plus Therapeutics Inc Revenue 2009–2025
Plus Therapeutics Inc annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Plus Therapeutics Inc revenue for the quarter ending March 31, 2026 was 1.0 M, a 2.93% decrease year-over-year.
- Plus Therapeutics Inc revenue for the twelve months ending March 31, 2026 was 4.9 M, a 4.71% decrease year-over-year.
- Plus Therapeutics Inc annual revenue for 2025 was 5.2 M, a 10.49% decrease from 2024.
- Plus Therapeutics Inc annual revenue for 2024 was 5.8 M, a 18.54% increase from 2023.
- Plus Therapeutics Inc annual revenue for 2023 was 4.9 M, a 33.83% increase from 2018.
- Plus Therapeutics Inc annual revenue for 2018 was 3.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Plus Therapeutics Inc Market Cap — FAQ
Plus Therapeutics Inc (PSTV) market cap over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PSTV's market cap history?
The chart and table above show Plus Therapeutics Inc's market cap by year and by quarter, including the growth rate.